Berlin Heart's paediatric LVAD (left-ventricular assist device) in "record-breaking" UK recovery success:
This article was originally published in Clinica
Executive Summary
Berlin Heart has hit the UK headlines with the successful use of an external cardiac-assist device for what is claimed to be a record-breaking time. After the 8-month baby was given the go-ahead to remove life-support due to the severity of a myocarditis-induced heart attack, the Freeman Hospital, in Newcastle, still decided to use Berlin's EXCOR Pediatric left-ventricular assist device (LVAD) as a bridge to transplant, with an outside chance of success. After 120 days supported by the LVAD, followed by a fortnight's recovery, the now 13-month old has left hospital. The Berlin, Germany company is wholly-owned by long-term medtech investment company Syscore, since October 2006.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.